论文部分内容阅读
Objective: A novel avian influenza virus H7N9 infection occurred among human populations since 2013.Although the lack of sustained human-to-human transmission limited the epidemics caused by H7N9, the late presentation of most patients and the emergence of neuraminidase-resistant strains made the development of novel antiviral strategy against H7N9 in urgent demands.